In order to optimize your use of our website we use cookies. If you want more information about our cookie policy, please read more here. By continuing, you agree to our use of cookies.

Close

logo

English
  • Svenska
  • About us
    About us
      • This is Calliditas
      • Vision and Strategy
      • Our Pipeline
      • Board of Directors
      • Management Team
      • Our History
      • Corporate Responsibility
      • Career
  • Disease overview
    Disease overview
      • IgA nephropathy
      • Nefecon
      • Orphan drugs
      • Other potential indications
      • Scientific Advisory Board
      • Clinical trials
        • Development program
  • Governance
    Governance
      • Corporate Governance
      • Corporate Governance Reports
      • Corporate Structure
      • General Meeting
        • Annual general meeting 2020
        • General meetings
      • Nomination Committee
        • Nomination committees
      • Board and Committees
        • Board of Directors
        • Board fees
        • Work of the Board of Directors
        • Committees
      • Management
        • Management team
      • Remuneration
      • Internal control and risk management
      • Auditor
      • Articles of Association
  • Investors
    Investors
      • The share
        • Trading information
        • Ownership structure
        • Share capital development
        • Dividend policy
        • Analyst coverage
      • Financial Reports and Presentations
      • SEC Filings
      • Archive old prospectuses
      • Press releases
      • Calendar
      • Subscribe
      • Contacts
      • Investor FAQs
      • Documentation Genkyotex tender offer
      • Capital Markets Day 2021
  • Media
    Media
      • Press releases
      • Calliditas in Media
      • Subscribe
      • Contacts
  • Contacts
    Contacts
      • Offices
      • Partnering
      • Investors
      • Media
  • Capital Markets Day 2021
  • Svenska

Calendar

2018
  • Upcoming events
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
Add to calendar
Aug 16, 2018

Interim report for the period January 1 – June 30, 2018

Add to calendar
Sep 7, 2018

NewsMakers in the Biotech Industry

Add to calendar
Nov 1, 2018

Interim report for the period January 1 – September 30, 2018

Add to calendar
Nov 13, 2018

Stifel 2018 Healthcare Conference

Add to calendar
Nov 14, 2018 - Nov 15, 2018

Jefferies 2018 London Healthcare Conference

Add to calendar
Dec 14, 2018

Extraordinary Shareholders’ Meeting 2018

Add to calendar
  • Investors
    • The share
      • Trading information
      • Ownership structure
      • Share capital development
      • Dividend policy
      • Analyst coverage
    • Financial Reports and Presentations
    • SEC Filings
    • Archive old prospectuses
    • Press releases
    • Calendar
    • Subscribe
    • Contacts
    • Investor FAQs
    • Documentation Genkyotex tender offer
    • Capital Markets Day 2021

Calliditas Therapeutics AB
Kungsbron 1, C8
SE-111 22 Stockholm
Sweden

Company number: 556659-9766

  • Privacy policy
  • About cookies

© Calliditas Therapeutics AB 2021